β-Catenin-Facilitated Glycolytic Reprogramming Fuels TNBC Progression: Therapeutic Blockade with XAV939. - Umar SM; Kahol S; Mathur SR; Gogia A; Deo SVS; Pandey S; Prasad CP (Technology in cancer research & treatment, 2026)